MedCity News |
Seventh Sense gets first FDA clearance for enclosed blood collection device
MedCity News On Thursday the U.S. FDA cleared Seventh Sense Biosystem's TAP phlebotomy device for use in hemoglobin A1c (HbA1c) testing, a standard parameter for diabetes management. That's the pilot test but there is a lot more to come, said Howard Weisman, ... |
from phlebotomy - Google News http://bit.ly/2lUmqDh
No comments:
Post a Comment